Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87
- PMID: 11780464
Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87
Abstract
Objective: To explore the apoptosis inducing effects of arsenic trioxide (As2O3) on human bladder cancer cells and elucidate possible mechanisms.
Methods: After treatment with As2O3, the growth inhibition rates of human bladder cancer cell line BIU-87 were studied by MTT and cell counts methods. DNA synthesis rates were detected by 3H-TdR assay. The morphological changes of cancer cells were observed by light and electronic microscopy and cell apoptosis rates were detected by TdT-mediated dUTP nick end labeling (TUNEL). bcl-2 gene expression of BIU-87 cells was observed by strept avidin-biotin complex (SABC) immunohistochemical method.
Results: As2O3 could effectively inhibit the growth of BIU-87 (P < 0.05), which were time and concentration dependent. The inhibition rate of 4.0 mumol/L As2O3 for DNA synthesis of cancer cells was 55.64% (P < 0.01). Partial cancer cells presented the characteristic morphological changes of apoptosis which depended on the time of exposure to drug (P < 0.05). bcl-2 expression of BIU-87 cells was decreased significantly (P < 0.05).
Conclusion: As2O3 can significantly induce apoptosis in bladder cancer cells by down-regulating the expression of the bcl-2 gene and inhibiting DNA synthesis. This provides a potentially effective method for prevention and cure of human bladder cancer.
Similar articles
-
Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide.Chin Med J (Engl). 2000 Jan;113(1):84-8. Chin Med J (Engl). 2000. PMID: 11775218
-
Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.Chin Med J (Engl). 2005 Jan 5;118(1):50-5. Chin Med J (Engl). 2005. PMID: 15642226
-
As2O3 induces apoptosis of the human B lymphoma cell line MBC-1.J Biol Regul Homeost Agents. 2000 Apr-Jun;14(2):116-9. J Biol Regul Homeost Agents. 2000. PMID: 10841286
-
Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):997-1001. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559676
-
Preliminary study of the in vitro growth inhibition of human bladder cancer cell line BIU-87 by arsenic trioxide.J Tongji Med Univ. 2000;20(2):112-5. doi: 10.1007/BF02887045. J Tongji Med Univ. 2000. PMID: 12845720
Cited by
-
The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study.BMC Med Genomics. 2008 Oct 9;1:48. doi: 10.1186/1755-8794-1-48. BMC Med Genomics. 2008. PMID: 18845002 Free PMC article.
-
Arsenic trioxide: insights into its evolution to an anticancer agent.J Biol Inorg Chem. 2018 May;23(3):313-329. doi: 10.1007/s00775-018-1537-9. Epub 2018 Feb 2. J Biol Inorg Chem. 2018. PMID: 29396610 Review.
-
Preparation of arsenic trioxide albumin microspheres and its release characteristics in vitro.J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):310-2, 319. doi: 10.1007/BF02828152. J Huazhong Univ Sci Technolog Med Sci. 2005. PMID: 16201281
-
Evaluation of Arsenic Trioxide Potential for Lung Cancer Treatment: Assessment of Apoptotic Mechanisms and Oxidative Damage.J Cancer Sci Ther. 2016 Jan;8(1):1-9. doi: 10.4172/1948-5956.1000379. Epub 2015 Dec 18. J Cancer Sci Ther. 2016. PMID: 27158419 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical